Exacerbation of adenomyosis in a postmenopausal woman taking tibolone associated with an elevation in serum CA 125

Ann Prys Davies, A P Davies, David Oram, D Oram
British journal of obstetrics and gynaecology · 1994 · vol. 101(7) , pp. 632–633 · doi:10.1111/j.1471-0528.1994.tb13658.x · PMID:8043545 · W1970754618
article OA: closed CC0 ⤵ 2 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex View on PubMed
⚙ AI-generated summary by claude@2026-06, 2026-06-09 ⓘ

This report describes a postmenopausal woman whose adenomyosis worsened, coinciding with increased serum CA 125 levels, during tibolone treatment.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosisadenomyosis

MeSH descriptors

Antigens, Tumor-Associated, Carbohydrate Endometriosis Estrogen Replacement Therapy Norpregnenes Uterine Neoplasms Antigens, Tumor-Associated, Carbohydrate Diagnosis, Differential Endometriosis Endometriosis Estrogen Replacement Therapy Female Humans Middle Aged Norpregnenes Postmenopause Uterine Neoplasms Uterine Neoplasms

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (1)

Cited by (2)

References (3)

Cited by (2)

Source provenance

europepmc
last seen: 2026-06-11T06:19:48.454388+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:11:24.284338+00:00
License: CC0 · commercial use OK